SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemcrux Enterprises informs about approval of equity shares

11 Feb 2026 Evaluate
Pursuant to the Regulation 30 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Chemcrux Enterprises has informed that the Company has received In-principle approval from BSE vide Letter No. DCS/ESOP/IP/RD/4061/2025-26 for 20,00,000 Equity shares of Rs 10 each to be issued under ‘Chemcrux Enterprises Employee Stock Option Scheme 2025’. The copy of approval letter received from BSE is attached.

The above information is a part of company’s filings submitted to BSE.

Chemcrux Enterprises Share Price

84.65 5.42 (6.84%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3611.60
Tata Chemicals 690.25
SRF 2471.15
Pidilite Inds. 1360.30
Deepak Nitrite 1465.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×